Literature DB >> 16558031

Streptolysin O II. Relationship of Sulfyhdryl Groups to Activity.

D E Van Epps1, B R Andersen.   

Abstract

Streptolysin O (SO), a group A streptococcal toxin, exists in two forms, a reduced active state and an oxidized reversibly inactive state. Activity is measured by red blood cell hemolysis. SO is a labile toxin, and, with time, activity is irreversibly lost. The rate of activity loss is slowed by incubation with 0.1 m 2-mercaptoethanol or 0.01 m ethylenediaminetetraacetic acid (EDTA). The effect of EDTA can be reversed by excess MgSO(4). Reversibly oxidized SO is activated by cleavage of disulfide bonds. When the free sulfhydryl groups of the active SO are alkylated with iodoacetamide, complete and irreversible loss of activity results. Periodate (0.01 m) oxidation also causes complete loss of activity which may be due to oxidation of sulfhydryl groups. SO in the active form reacts with Fe(2+), Cu(2+), Ca(2+), and Mg(2+), causing loss of activity in various degrees depending on the ions and the concentration used. Ferric and cupric ions are most effective and cause loss of activity at concentrations on the order of 10(-4)m. The reversibly oxidized form of SO is not influenced by exposure to cupric ions (0.01 m), indicating that the reaction is only with the active form of SO, probably involving the free sulfhydryl groups. These groups may be responsible for the direct binding of the toxin to the target membrane or for the maintenance of the proper conformation for activity.

Entities:  

Year:  1971        PMID: 16558031      PMCID: PMC416211          DOI: 10.1128/iai.3.5.648-652.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  FURTHER OBSERVATIONS ON IN VITRO RADIOSENSITIZATION OF RABBIT ERYTHROCYTES BY IODOACETIC ACID AND RELATED SUBSTANCES.

Authors:  M R BIANCHI; M BOCCACCI; P MISITI-DORELLO; M QUINTILIANI
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1964

2.  LYSIS OF PLEUROPNEUMONIA-LIKE ORGANISMS BY STAPHYLOCOCCAL AND STREPTOCOCCAL TOXINS.

Authors:  A W BERNHEIMER; M DAVIDSON
Journal:  Science       Date:  1965-05-28       Impact factor: 47.728

3.  Effects of mild eriodate oxidation on antibodies.

Authors:  B R Andersen; D C Abele; W E Vannier
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

Review 4.  Cytolytic toxins of bacterial origin. The nature and properties of cytolytic proteins are discussed with emphasis on staphylococcal alpha-toxin.

Authors:  A W Bernheimer
Journal:  Science       Date:  1968-02-23       Impact factor: 47.728

5.  Streptolysin O: sedimentation coefficient and molecular weight determinations.

Authors:  D E Van Epps; B R Andersen
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

6.  Kinetics of streptolysin O reactivation by different thiols.

Authors:  S Rahman; P Rebeyrotte; B Halpern; D Besluau
Journal:  Biochim Biophys Acta       Date:  1969-05-06

7.  Some observations on the periodate oxidation of amino compounds.

Authors:  J R Clamp; L Hough
Journal:  Biochem J       Date:  1966-10       Impact factor: 3.857

8.  The analysis of streptococcal infections. V. Cardiotoxicity of streptolysin O for rabbits in vivo.

Authors:  S P HALBERT; R BIRCHER; E DAHLE
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307

9.  The toxicity of streptolysin O for beating mammalian heart cells in tissue culture.

Authors:  A Thompson; S P Halbert; U Smith
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  An analysis of the toxic actions of purified streptolysin O on the isolated heart and separate cardiac tissues of the guinea pig.

Authors:  B A Reitz; D J Prager; G A Feigen
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  10 in total

1.  Cellular location of streptolysin O.

Authors:  G B Calandra; T S Theodore
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.

Authors:  H Nagamune; C Ohnishi; A Katsuura; K Fushitani; R A Whiley; A Tsuji; Y Matsuda
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Phenomenon of hot-cold hemolysis: chelator-induced lysis of sphingomyelinase-treated erythrocytes.

Authors:  C J Smyth; R Möllby; T Wadström
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

4.  Isolation of streptolysin O by preparative polyacrylamide gel electrophoresis.

Authors:  D E Van Epps; B R Andersen
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

5.  Interaction of streptolysin O from Streptococcus pyogenes and theta-toxin from Clostridium perfringens with human fibroblasts.

Authors:  M Thelestam; R Möllby
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Automated determination of anti-streptolysin O antibodies by a kinetic hemolytic method.

Authors:  A Ricci; C Arezzini; F Cocola; F Meiattini
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

7.  Characteristics of streptolysin O action.

Authors:  T D Oberley; J L Duncan
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

8.  Purification of cereolysin and the electrophoretic separation of the active (reduced) and inactive (oxidized) forms of the purified toxin.

Authors:  J L Cowell; P S Grushoff-Kosyk; A W Bernheimer
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  New hemolytic method for determination of antistreptolysin O in whole blood.

Authors:  A Ricci; B Berti; C Moauro; M Porro; P Neri; P Tarli
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

10.  Pathogenicity Induced by Invasive Infection of Streptococcus dysgalactiae subsp. equisimilis in a Mouse Model of Diabetes.

Authors:  Kohei Ogura; Kayo Okumura; Yukiko Shimizu; Teruo Kirikae; Tohru Miyoshi-Akiyama
Journal:  Front Microbiol       Date:  2018-09-21       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.